Drug Shortage Report for ROFACT
Report ID | 65751 |
Drug Identification Number | 00343617 |
Brand name | ROFACT 300MG |
Common or Proper name | ROFACT 300MG |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | RIFAMPIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | J04AB |
ATC description | DRUGS FOR TREATMENT OF TUBERCULOSIS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-05-02 |
Estimated end date | |
Actual end date | 2019-07-29 |
Shortage status | Resolved |
Updated date | 2019-08-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2019-06-13 | English | Compare |
v22 | 2019-06-13 | French | Compare |
v23 | 2019-06-13 | English | Compare |
v24 | 2019-06-13 | French | Compare |
v25 | 2019-06-13 | English | Compare |
v26 | 2019-06-13 | French | Compare |
v27 | 2019-06-13 | English | Compare |
v28 | 2019-06-13 | English | Compare |
v29 | 2019-06-13 | French | Compare |
v30 | 2019-06-18 | English | Compare |
v31 | 2019-06-18 | French | Compare |
v32 | 2019-07-24 | English | Compare |
v33 | 2019-07-24 | French | Compare |
v34 | 2019-08-01 | English | Compare |
v35 | 2019-08-01 | French | Compare |